184 related articles for article (PubMed ID: 22171504)
1. [Mechanism of diabetes-induced microvascular damage and therapeutic potential of ROCK inhibition].
Arita R
Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):985-97. PubMed ID: 22171504
[TBL] [Abstract][Full Text] [Related]
2. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
3. A key role for ROCK in TNF-α-mediated diabetic microvascular damage.
Arita R; Nakao S; Kita T; Kawahara S; Asato R; Yoshida S; Enaida H; Hafezi-Moghadam A; Ishibashi T
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2373-83. PubMed ID: 23462755
[TBL] [Abstract][Full Text] [Related]
4. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
Hofni A; Shehata Messiha BA; Mangoura SA
Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
[TBL] [Abstract][Full Text] [Related]
5. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase.
McGown CC; Brown NJ; Hellewell PG; Brookes ZL
Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186
[TBL] [Abstract][Full Text] [Related]
6. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
7. Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.
Pearson JT; Jenkins MJ; Edgley AJ; Sonobe T; Joshi M; Waddingham MT; Fujii Y; Schwenke DO; Tsuchimochi H; Yoshimoto M; Umetani K; Kelly DJ; Shirai M
Cardiovasc Diabetol; 2013 Aug; 12():111. PubMed ID: 24059472
[TBL] [Abstract][Full Text] [Related]
8. [Preventive strategy for the treatment of diabetic vitreoretinopathy].
Hata Y
Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):379-401; discussion 402. PubMed ID: 19348184
[TBL] [Abstract][Full Text] [Related]
9. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
10. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
11. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
[TBL] [Abstract][Full Text] [Related]
12. Rho-Associated Protein Kinase-1 Mediates the Regulation of Inflammatory Markers in Diabetic Retina and in Retinal Müller Cells.
Mohammad G; AlSharif HM; Siddiquei MM; Ahmad A; Alam K; Abu El-Asrar AM
Ann Clin Lab Sci; 2018 Mar; 48(2):137-145. PubMed ID: 29678838
[TBL] [Abstract][Full Text] [Related]
13. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation/miRNA pathway.
Li T; Yang GM; Zhu Y; Wu Y; Chen XY; Lan D; Tian KL; Liu LM
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E257-69. PubMed ID: 25425000
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury.
Park JW; Park CH; Kim IJ; Bae EH; Ma SK; Lee JU; Kim SW
J Pharmacol Exp Ther; 2011 Jul; 338(1):271-9. PubMed ID: 21474569
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition by fasudil exerts antioxidant effects in hypercholesterolemic rats.
Ma Z; Zhang J; Ji E; Cao G; Li G; Chu L
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):688-94. PubMed ID: 21711379
[TBL] [Abstract][Full Text] [Related]
17. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion.
Li H; Peng W; Jian W; Li Y; Li Q; Li W; Xu Y
Cardiovasc Diabetol; 2012 Jun; 11():65. PubMed ID: 22694757
[TBL] [Abstract][Full Text] [Related]
18. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
Zhang L; Li Q; Liu Z; Liu W; Zhao M
Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
[TBL] [Abstract][Full Text] [Related]
19. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, ameliorates hepatic fibrosis in rats with type 2 diabetes.
Zhou H; Fang C; Zhang L; Deng Y; Wang M; Meng F
Chin Med J (Engl); 2014; 127(2):225-31. PubMed ID: 24438608
[TBL] [Abstract][Full Text] [Related]
20. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
Zhu L; Wang W; Xie TH; Zou J; Nie X; Wang X; Zhang MY; Wang ZY; Gu S; Zhuang M; Tan J; Shen C; Dai Y; Yang X; Yao Y; Wei TT
FASEB J; 2020 Mar; 34(3):4189-4203. PubMed ID: 31957105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
